全文获取类型
收费全文 | 705篇 |
免费 | 29篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 9篇 |
妇产科学 | 1篇 |
基础医学 | 116篇 |
口腔科学 | 1篇 |
临床医学 | 111篇 |
内科学 | 22篇 |
皮肤病学 | 5篇 |
神经病学 | 237篇 |
特种医学 | 12篇 |
外科学 | 124篇 |
综合类 | 77篇 |
预防医学 | 16篇 |
眼科学 | 3篇 |
药学 | 10篇 |
中国医学 | 14篇 |
肿瘤学 | 4篇 |
出版年
2024年 | 1篇 |
2023年 | 13篇 |
2022年 | 16篇 |
2021年 | 27篇 |
2020年 | 23篇 |
2019年 | 14篇 |
2018年 | 19篇 |
2017年 | 16篇 |
2016年 | 19篇 |
2015年 | 13篇 |
2014年 | 29篇 |
2013年 | 60篇 |
2012年 | 22篇 |
2011年 | 34篇 |
2010年 | 35篇 |
2009年 | 49篇 |
2008年 | 23篇 |
2007年 | 28篇 |
2006年 | 32篇 |
2005年 | 29篇 |
2004年 | 28篇 |
2003年 | 22篇 |
2002年 | 25篇 |
2001年 | 17篇 |
2000年 | 10篇 |
1999年 | 18篇 |
1998年 | 10篇 |
1997年 | 17篇 |
1996年 | 4篇 |
1995年 | 11篇 |
1994年 | 13篇 |
1993年 | 14篇 |
1992年 | 6篇 |
1991年 | 12篇 |
1990年 | 3篇 |
1989年 | 7篇 |
1988年 | 6篇 |
1987年 | 5篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有765条查询结果,搜索用时 0 毫秒
81.
Lúcia Inês Macedo-Souza Fernando Kok † Silvana Santos Luciana Licinio Karina Lezirovitz Natale Cavaçana Clarissa Bueno Simone Amorim ré Pessoa Zodja Graciani Áurea Ferreira Abdísio Prazeres Áurea Nogueira de Melo Paulo Alberto Otto Mayana Zatz 《Annals of human genetics》2009,73(3):382-387
SPOAN is an autosomal recessive neurodegenerative disorder which was recently characterized by our group in a large inbred Brazilian family with 25 affected individuals. This condition is clinically defined by: 1. congenital optic atrophy; 2. progressive spastic paraplegia with onset in infancy; and 3. progressive motor and sensory axonal neuropathy. Overall, we are now aware of 68 SPOAN patients (45 females and 23 males, with age ranging from 5 to 72 years), 44 of which are presented here for the first time. They were all born in the same geographic micro region. Those 68 patients belong to 43 sibships, 40 of which exhibit parental consanguinity. Sixty-one patients were fully clinically evaluated and 64 were included in the genetic investigation. All molecularly studied patients are homozygotes for D11S1889 at 11q13. This enabled us to reduce the critical region for the SPOAN gene from 4.8 to 2.3 Mb, with a maximum two point lod score of 33.2 (with marker D11S987) and of 27.0 (with marker D11S1889). Three genes located in this newly defined critical region were sequenced, but no pathogenic mutation was detected. The gene responsible for SPOAN remains elusive. 相似文献
82.
A Boukhris G Stevanin I Feki P Denora N Elleuch MI Miladi C Goizet J Truchetto S Belal A Brice and C Mhiri 《Clinical genetics》2009,75(6):527-536
Hereditary spastic paraplegias (HSP) constitute a clinically and genetically heterogeneous group of neurodegenerative disorders characterized by slowly progressive spasticity of the lower extremities. We performed the first clinical, epidemiological and genetic study of HSP in Southern Tunisia. We investigated 88 patients belonging to 38 unrelated Tunisian HSP families. We could establish the minimal prevalence of HSP in the district of Sfax at 5.75/100,000. Thirty‐one percent of the families had a pure HSP, whereas 69% had a complicated form. The mode of inheritance was almost exclusively compatible with an autosomal recessive trait (97%, 37/38). Taking into account previously published results and new data generated in this work, genetic studies revealed significant or putative linkage to known HSP loci in 13 families (34.2%) to either SPG11 (7/38, 18.4%), SPG15 (4/38, 10.5%) or to SPG4 and SPG5 in one family each. The linkage results could be validated through the identification of two recurrent truncating mutations (R2034X and M245VfsX246) in the SPG11 gene, three different mutations (Q493X, F683LfsX685 and the novel S2004T/r.?) in the SPG15 gene, the recurrent R499C mutation in the SPG4 gene as well as the new R112X mutation in the SPG5 gene. SPG11 and SPG15 are the major responsible HSP genes in Tunisia. 相似文献
83.
遗传性痉挛性截瘫SPG4和SPG3A基因突变和多态分析 总被引:1,自引:0,他引:1
目的 筛查并分析遗传性痉挛性截瘫(HSP)SPG4和SPG3A基因突变,了解中国人群这2个基因的突变特点.方法 联合应用变性高效液相色谱分析(DHPLC)和DNA序列分析方法对24例常染色体显性遗传的HSP(AD-HSP)家系的先证者和32例散发性HSP患者进行SPG4和SPG3A基因突变筛查,对24例AD-HSP家系的先证者进一步直接测序筛查这2个基因的突变.结果 在1个AD-HSP家系中发现1个位于SPG4基因上的新犁突变1616+1g→t杂合突变.在此家系中,共发现了3例现症患者和2例症状前患者.本组病例未检出SPG3A基因突变.此外,共发现了8种新的SPG4多态和3种新的SPG3A多态.结论 本组检测结果 丰富了SPG4和SPG3A基因的突变和多态库.这2个基因突变在本组病例中较少见,需要继续分析其他基因. 相似文献
84.
Bauer P Winner B Schüle R Bauer C Häfele V Hehr U Bonin M Walter M Karle K Ringer TM Riess O Winkler J Schöls L 《Neurogenetics》2009,10(1):43-48
Mutations in the spatacsin gene have recently been identified as the genetic cause of autosomal–recessive spastic paraplegia (SPG) with thin corpus callosum,
mapping to chromosome 15p13–21. While several nonsense and frameshift mutations as well as splice mutations have been identified,
large genomic deletions have not yet been found, potentially due to the absence of an efficient analysis tool. After complete
sequencing of 12 autosomal recessive hereditary spastic paraplegia patients with suggestive clinical signs, we were able to
define nine SPG11 cases but were left with three patients in which only one SPG11 mutation could be identified by direct sequencing.
In these patients, we performed high-resolution comparative genomic hybridization using a predesigned human chromosome 15
tiling array with an average spacing of 100 bp. Data analysis suggested heterozygous genomic deletion within the spatacsin gene in all three patients. In one patient, a relatively small genomic deletion (8.2 kb) could be validated by quantitative polymerase
chain reaction (PCR) and long-range PCR, allowing the diagnosis of the deletion of exons 31 through 34. For two patients,
quantitative PCR validation could not confirm a genomic deletion. As high density tiling arrays are available for the entire
human genome, we suggest this approach for the screening of heterozygous genomic deletions in candidate genes down to a few
kilobases. 相似文献
85.
86.
《European journal of medical genetics》2017,60(12):639-642
Defects of phospholipids remodelling and synthesis are inborn errors of metabolism responsible for various clinical presentations including spastic paraplegia, retinopathy, optic atrophy, myo- and cardiomyopathies, and osteo-cutaneous manifestations. DDHD1 encodes a phospholipase A1, which is involved in the remodelling of phospholipids. We previously described a relatively pure hereditary spastic paraplegia (HSP) phenotype associated with mutations in DDHD1. Here we report a complex form of HSP associated with retinal dystrophy and a pattern of neurodegeneration with brain iron accumulation (NBIA) on brain MRI, due to a novel homozygous mutation in DDHD1. This observation enlarges the clinical spectrum of DDHD1-associated disorders and sheds light on a new aetiology for syndromes associating retinopathy and NBIA. It also emphasizes the role of complex lipids in the retina. 相似文献
87.
88.
Mitochondrial Membrane-protein Associated Neurodegeneration (MPAN) is a rare disease, caused by C19orf12 mutations and up to 29 different mutations have been described. We report a young woman presented with spastic paraparesis due to C19orf12 gene. MPAN presenting like Hereditary spastic paraplegia-43 is rare and the genetic mutation had been described only once in the literature. 相似文献
89.
90.
R. Battini A. Fogli D. Borghetti A. Michelucci S. Perazza F. Baldinotti M. E. Conidi M. I. Ferreri P. Simi G. Cioni 《European journal of neurology》2011,18(1):150-157
Background: Hereditary spastic paraplegias (HSP) are a group of neurodegenerative disorders characterized by progressive lower extremity spastic weakness. SPG7, SPG4 and SPG3A are some of the autosomal genes recently found as mutated in recessive or dominant forms of HSP in childhood. SPG31 is more often associated with a pure spastic paraplegia phenotype, but genotype–phenotype correlation is still unclear. The aims of the current study was: (i) to verify the mutational frequency of SPG4, SPG3A, SPG31 and SPG7 genes in our very‐well‐selected childhood sample, and (ii) to improve our knowledge about the clinical and electrophysiological HSP phenotypes and their possible correlation with a specific mutation. Methods: A sample of 14 Italian children affected by pure HSP (mean age at diagnosis 5.9 years) was extensively investigated with electrophysiological, neuroradiological and genetic tests. Results: Three SPG4 mutations were identified in three patients: two novel missense mutations, both sporadic, and one multiexonic deletion already reported. A novel large deletion in SPG31 gene involving exons 2–5 was also detected in one young patient. No mutations in the SPG7 and in the SPG3A genes were found. Conclusions: Our data confirm that HSP represent a heterogeneous group of genetic neurodegenerative disorders, also in sporadic or autosomal recessive early onset forms. Multiplex Ligation‐dependent Probe Amplification‐based mutation screening for SPG4 and SPG31 genes would be added to sequencing‐based screening of SPG4, SPG31 and SPG3A genes in the routine diagnosis of HSP children. 相似文献